Tanaka N - Search Results

1

Optimal and effective oral dose of taurine to prolong exercise performance in rat.

Miyazaki T, Matsuzaki Y, Ikegami T, Miyakawa S, Doy M, Tanaka N, Bouscarel B. Miyazaki T, et al. Among authors: tanaka n. Amino Acids. 2004 Dec;27(3-4):291-8. doi: 10.1007/s00726-004-0133-1. Epub 2004 Oct 22. Amino Acids. 2004. PMID: 15503230

2

Suppression of hepatic lesions in a murine graft-versus-host reaction by antibodies against adhesion molecules.

Itoh S, Matsuzaki Y, Kimura T, Unno R, Ikegami T, Shoda J, Doy M, Fujiwara M, Tanaka N. Itoh S, et al. Among authors: tanaka n. J Hepatol. 2000 Apr;32(4):587-95. doi: 10.1016/s0168-8278(00)80220-2. J Hepatol. 2000. PMID: 10782907

3

The chemopreventive role of ursodeoxycholic acid in azoxymethane-treated rats: suppressive effects on enhanced group II phospholipase A2 expression in colonic tissue.

Ikegami T, Matsuzaki Y, Shoda J, Kano M, Hirabayashi N, Tanaka N. Ikegami T, et al. Among authors: tanaka n. Cancer Lett. 1998 Dec 25;134(2):129-39. doi: 10.1016/s0304-3835(98)00248-1. Cancer Lett. 1998. PMID: 10025872

4

Biochemical and histological changes after more than four years of treatment of ursodeoxycholic acid in primary biliary cirrhosis.

Matsuzaki Y, Doy M, Tanaka N, Shoda J, Osuga T, Nakano M, Aikawa T. Matsuzaki Y, et al. Among authors: tanaka n. J Clin Gastroenterol. 1994 Jan;18(1):36-41. doi: 10.1097/00004836-199401000-00010. J Clin Gastroenterol. 1994. PMID: 8113583

5

Novel murine autoimmune-mediated liver disease model induced by graft-versus-host reaction and concanavalin A.

Unno R, Matsuzaki Y, Itoh S, Doy M, Shoda J, Tanaka N. Unno R, et al. Among authors: tanaka n. J Gastroenterol Hepatol. 2001 Oct;16(10):1149-57. doi: 10.1046/j.1440-1746.2001.02580.x. J Gastroenterol Hepatol. 2001. PMID: 11686843

6

Clinical significance of the trimethadione tolerance test in chronic hepatitis: a useful indicator of hepatic drug metabolizing capacity.

Abei M, Tanaka E, Tanaka N, Matsuzaki Y, Ikegami T, Ishikawa A, Osuga T. Abei M, et al. Among authors: tanaka n, tanaka e. J Gastroenterol. 1995 Aug;30(4):478-84. doi: 10.1007/BF02347564. J Gastroenterol. 1995. PMID: 7550858

7

Randomized control trial of lipo-prostaglandin E1 in patients with acute liver injury induced by lipiodol-targeted chemotherapy.

Ikegami T, Matsuzaki Y, Kurusu J, Yoshiga S, Saito Y, Chiba T, Abei M, Shoda J, Tanaka N, Osuga T. Ikegami T, et al. Among authors: tanaka n. Clin Pharmacol Ther. 1995 May;57(5):582-9. doi: 10.1016/0009-9236(95)90043-8. Clin Pharmacol Ther. 1995. PMID: 7768081 Clinical Trial.

8

Severe acute hepatitis A associated with acute pure red cell aplasia.

Tomida S, Matsuzaki Y, Nishi M, Ikegami T, Chiba T, Abei M, Tanaka N, Osuga T, Sato Y, Abe T. Tomida S, et al. Among authors: tanaka n. J Gastroenterol. 1996 Aug;31(4):612-7. doi: 10.1007/BF02355068. J Gastroenterol. 1996. PMID: 8844489 Review.

9

Cytokine profile of liver-infiltrating CD4+ T cells separated from murine primary biliary cirrhosis-like hepatic lesions induced by graft-versus-host reaction.

Itoh S, Matsuzaki Y, Kimura T, Ikegami T, Shoda J, Fujiwara M, Tanaka N. Itoh S, et al. Among authors: tanaka n. J Gastroenterol Hepatol. 2000 Apr;15(4):443-51. doi: 10.1046/j.1440-1746.2000.02068.x. J Gastroenterol Hepatol. 2000. PMID: 10824891

10

HBV genome integration and genetic instability in HBsAg-negative and anti-HCV-positive hepatocellular carcinoma in Japan.

Matsuzaki Y, Chiba T, Hadama T, Asaoka H, Doy M, Shoda J, Tanaka N, Kinoshita M. Matsuzaki Y, et al. Among authors: tanaka n. Cancer Lett. 1997 Oct 28;119(1):53-61. doi: 10.1016/s0304-3835(97)00249-8. Cancer Lett. 1997. PMID: 18372522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,553 results

Search Page

Filters